Four details:
1. U.S. District Court Judge Gloria Navarro ruled that Mr. Claridge could move forward with a lawsuit claiming that the companies’ representatives misrepresented the safety of I-Flow’s On-Q pain pump.
2. Mr. Claridge, who had a four-year contract with the Patriots beginning in 2005, alleged that the pain pump was misrepresented as safe to use on joints and destroyed his shoulder cartilage when surgically implanted.
3. The FDA had cautioned that the pump could destroy joint cartilage, causing chondrolysis. I-Flow amended the device’s label in 2006 to reflect that risk.
4. Part of Mr. Claridge’s lawsuit was dismissed, but he may still seek punitive damages based on the amended complaint.
More articles on sports medicine:
Dr. Manny Sethi to step down from nonprofit to focus on US Senate campaign
Why 2019 is shaping up to be an important year for Zimmer Biomet — 5 things to know
Husband-wife neurosurgeon team bring 24-hour neurosurgery back to Arkansas hospital
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
